Company Filing History:
3 out of 198 
2 out of 4,455 
1 out of 832,812 Years Active: 2000-2025
Title: The Innovations of Matthew Curtis Griffor: A Pioneer in Biochemical Patents
Introduction
Matthew Curtis Griffor, based in North Stonington, CT, is an accomplished inventor with a remarkable portfolio comprising six patents. His work focuses primarily on biochemical innovations, showcasing a distinct ability to enhance and modify polypeptides for various applications in medical science.
Latest Patents
Matthew Griffor's latest contributions to the field include breakthroughs such as the patent for FimH mutants and uses thereof. This invention pertains to the engineering of mutated FimH polypeptides, aiming to improve their biochemical properties and immunogenicity. Additionally, he has developed a patent related to the Human Cytomegalovirus gB polypeptide. This invention involves polypeptides and cytomegalovirus (CMV) antigens with specific amino acid mutations compared to wild-type HCMV glycoprotein B. Notably, the polypeptide is engineered to stabilize in an alternative conformation that differs from the gB post-fusion conformation, thereby expanding its potential applications.
Career Highlights
Throughout his career, Matthew Griffor has worked with prominent organizations, including Dekalb Genetics Corporation and Pfizer Corporation. His positions at these companies have allowed him to contribute significantly to the advancement of biochemical research and development, further establishing his reputation as a leading inventor in the industry.
Collaborations
In his professional journey, Matthew has collaborated with esteemed colleagues such as Paul C. Anderson and Paul S. Chomet. These partnerships have facilitated the exchange of ideas and expertise, resulting in innovative solutions and advancements in their respective fields.
Conclusion
Matthew Curtis Griffor stands out as a pivotal figure in the realm of biochemical inventions. With his innovative patents, extensive career experience, and successful collaborations, he continues to influence the development of new technologies that can lead to improved health outcomes. His work exemplifies the importance of creativity and collaboration in scientific research, ultimately contributing to the evolving landscape of biotechnology.